Screener
AngioDynamics ANGO Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| Line item | Year ended May 31, 2026 | Year ended May 31, 2025 | Year ended May 31, 2024 |
|---|---|---|---|
| Net sales | $320,174 | $292,498 | $303,914 |
| Cost of sales (exclusive of intangible amortization) | 145,282 | 134,793 | 149,216 |
| Gross margin | 174,892 | 157,705 | 154,698 |
| Operating expenses | |||
| Research and development | 29,447 | 26,222 | 31,512 |
| Sales and marketing | 113,401 | 103,135 | 102,818 |
| General and administrative | 43,691 | 42,092 | 41,164 |
| Amortization of intangibles | 10,682 | 10,318 | 13,048 |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's total cost of revenue?
- AngioDynamics (ANGO) reported total cost of revenue of $39.83M in Q1 2026.
- How has AngioDynamics's total cost of revenue changed year-over-year?
- AngioDynamics's total cost of revenue increased by 5.0% year-over-year, from $37.94M to $39.83M.
- What is the long-term trend for AngioDynamics's total cost of revenue?
- Over 4 years (2022 to 2026), AngioDynamics's total cost of revenue has grown at a -0.9% compound annual growth rate (CAGR), from $150.49M to $145.28M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about AngioDynamics's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude